Entrar Registro gratuito

Panbela Therapeutics Propriedade de acionista maioritário

Qual é o Propriedade de acionista maioritário de Panbela Therapeutics?

O Propriedade de acionista maioritário de Panbela Therapeutics Inc. é 14.55%

Qual é a definição de Propriedade de acionista maioritário?



A propriedade de acionistas maioritários é calculada como o número total de ações pertencentes aos acionistas maioritários (acionistas que possuem mais de 5% da corporação ou um executivo ou diretor da empresa) dividido pelo total de ações em circulação.

A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.

A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.

Propriedade de acionista maioritário de empresas na Setor Health Care em NASDAQ em comparação com Panbela Therapeutics

O que Panbela Therapeutics faz?

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.

Empresas com propriedade de acionista maioritário semelhantes a Panbela Therapeutics